Drug molecule contains various reactive functional groups which are susceptible to react with another reactive functional groups which might be excipients, excipient or drugs impurities formed during manufacturing or storage. The objective of the current review article is to provide a comprehensive review of excipients-drug compatibility study, their degradation product characterization with different analytical methods and further impact of methodologies in pharmaceutical industry for potential stability assessment. The incompatibility of drug excipient was very common due to the reactive functional groups in drugs and excipients. These leads to formation of drug related impurities as well as excipient impurities reaction with active Pharmaceutical Ingredients. Sometimes these impurities found to be mutagenic and genotaxic to human beings. Identification of drug degradation in presence of excipient impurities requires extensive knowledge and adequate analytical characterization data. Systematic literature review and understanding about the drug-excipient chemistry in formulation process is important criteria to select compatible excipient and formulate ideal formulation. The analytical characterization data gives idea about degradation pathway. This paper discusses drug-excipient interactions, compatibility and characterization by different analytical methods with case studies and provides an overview of different excipients compatibility in formulation. Gupta et al.; AJOCS, 6(3): 1-22, 2019; Article no.AJOCS.51941 2
INTRODUCTION
Different dosage forms like tablets, capsules, oral liquids, injectable products, implants, eye products, nasal products, inhalers, topical creams and gels, transdermal patches and suppositories etc, contains different types of excipients. To make it acceptable and compatible various pharmaceutical excipients are added in pharmaceutical dosage form for their direct therapeutic action, manufacturing process, to protect, support or enhance stability, for bioavailability or patient compliance. The common excipients used in tablets are listed in Table 1 [1] .
Drug degradation catalyzed by excipients impurity reaction with reactive functional groups of organic active pharmaceutical ingredient. Functionality, compatibility between the drug and excipients are the most important criteria for the selection of pharmaceutical excipients and their concentrations in formulation. Because of an incompatibility between drug and excipient in the formulation affect the various pharmaceutical properties like changes in physical, chemical, microbiological or therapeutic properties of the dosage form. Various analytical methods incorporated mainly to estimate the potential incompatibility of the drug, degradation pathways, impurities and their concentration in the final dosage form to prevent further incompatability. The common pharmaceutical excipients and their potentially reactive impurities are listed in Table 2 .
Many formulations undergo reactions such as hydrolysis, isomerization, dehydration, oxidation, photodegradation, elimination, cyclization and specific interactions with formulation excipients and their impurities observed in pharmaceuticals. Interaction and incompatabilities of the excipients with functional groups and different types of reaction are listed in Table 3 . The environmental factors such as temperature, pH and moisture in solids, relative humidity of the environment, presence of catalysts, light, oxygen etc, and acts like a catalyst to initiation of drug excipients reaction. Moisture increases the microenvironmental pH in the dosage form leads to acid-base catalysis reaction of drug excipients and source of impurities results in drug degradation [2].
Isothermal Stress Testing
In isothermal stress testing, drug excipient blends in the presence of moisture (20%) exposed to constant temperature for specific period of time. The total no. of drug excipient blends were planned as per statistical design. 
Protocol for Compatibility Testing
Compatibility studies designed to identify key drug-excipient incompatibilities, causes and effects. Compatibility studies started with the evaluation of existing information and chemistry of the new molecular entities to identify "soft spots" in the molecule. 
Experimental Design of Compatibility Study
It involves 
Impurities Present in the Excipients
Various pharmaceutical excipients used in formulation for different purposes, but due to their own degradation or incompatibilities with drugs. Table  2 shows various excipients, reactive impurities and known incompatability. 
Interaction and Incompatabilities of the Excipients with Functional Groups [4]
Different excipients have different chemical nature, different functional groups and different reactivity towards other functional groups of drug or excipients Table 3 . shows interaction and incompatabilities of the excipients with functional groups and different types of reaction which was observed commonly. 
In

SACCHARIDES
Lactose
Lactose disaccharide reducing sugar is the most commonly used excipients in various pharmaceutical oral unit dosage forms but potentially react with drugs containing amino groups. The sequence of such reaction is referred to as the Maillard reaction. The literature survey reveals the incompatibility of lactose with amine-containing APIs. Micheal addition reaction with primary amine result in formation of 1-4 addition products between the drug and the maleic acid propogated by the free moisture associated with the starch. Pregelatinized starch showed Such type of formation of the 1,4addition reaction which finally leads to the formation of maillard reaction product [6]. 
Fig. 3. Simplified scheme of the Maillard reaction
The mechanism of the Maillard reaction is very complicated; however, it is generally divided into three stages.
1) The first stage involves the sugar-amine condensation and the Amadori rearrangement. The reaction steps have been well-defined and no browning occurs at this stage.
2) The second stage involves sugar dehydration and fragmentation, and amino acid degradation via the Strecker reaction especially at high temperatures. 3) Formation of heterocyclic nitrogen compounds. Browning occurs at this stage.
[7,8]. to the formation of an imine known as a Schiff's base. In the baclofen FTIR spectrum,Adduct mixtures showed C=N stretching indicating convertion of imine into its isomeric enamine form during the Maillard reaction [9].
Baclofen
Doxepin
Physicochemical incompatibility of doxepin with dextrose was evaluated in solid-state mixtures and the compatibility was characterized by using different physicochemical methods such as DSC, Fourier transform infrared spectroscopy and mass spectrometry. The melting endothermic peak of doxepin hydrochloride was disappeared in the doxepin hydrochloride-dextrose binary mixture and the dissolution of the drug particles inside the melted excipients and a new peak appeared due to incompatability.IR spectra of Dextrose-doxepin hydrochloride showd a new peak at 1647 cm-1,due to C=N covalent band indicating incompatibilitydue to Maillard-type reaction.The full-scan positive-ion electrospray product ion mass spectra showed that the molecular ion of doxepin hydrochloride was a protonated molecules, formed condensation product B and Amadori rearrangement product labeled as condensation product-A [10] .
Fluoxetine
Drugs which contains secondary amines also can undergo the Maillard reaction with lactose under pharmaceutically relevant conditions. Fluoxetine was characterized by NMR, GC-MS,HPLC. The fluoxetine undergo Maillard reaction and formed N-Formylfluoxetine as a major product. Also GC/MS characterization study reported various characteristic volatile products of the Maillard reaction, including furaldehyde,maltol, and 2,3-dihydro-3,5dihydroxy-6-methyl 4H-pyran-4-one [11] .
Memantine
Maillard reaction of Memantine identified by gradient high performance liquid chromatographic (HPLC) method using charged aerosol detection (CAD). Reported impurities are memantine-lactose adduct (ML), a memantinedimethylamino glycine adduct (DMAG), a memantine-galactose adduct (MGAL) and a memantine-glucose adduct (MGLU) [ 
Fig. 8. Schematic diagram showing Maillard reaction between lactose and memantine 2.6 Sitagliptin
Formation of the imine bond with sitagliptin found in the presence of lactose (the Maillard reaction) at high temperature and high humidity and it is characterized by FTIR and LC-MS. In LC-MS characterization other various degradation products were found [13] .
Abacavir
Two newer interaction products (ALm 1 and ALm 2) generated due to reaction between Abacavir and lactose which was characterized by hyphenated analytical techniques like LC-MS/TOF and NMR, further evaluated using in silico drug designs, in-silico toxicity and ADMET properties, whereas interaction products were analysed using TOPKAT and ADMETTM software and compared to the drug [14] .
Nebivolol
Nebivolol (NEB)-lactose adduct formed in unbuffered solution, buffered alkaline solutions and dry physical mixture and Maillard adduct characterized by FTIR, HPLC and LC-MS. Due to adduct formation of the NEB-lactose adduct results in highly significant loss in the bradycardic effect of NEB [15] . 
MAGNESIUM STEARATE
Magnesium stearate is the salt of a complex mixture of fatty acids, with the main component as stearate and palmitate. It has multiple crystalline forms and an amorphous form [16] . Various researchers reported magnesium incompatibilitywith drug.
Moexipril Hydrochloride (Moxl), Imidapril Hydrochloride (Imd), Enalapril Maleate, (Ena) and Lisinopril (Lis) in Solid State with Magnesium Stearate
Incompatibilitybetween moexipril hydrochloride (MOXL), imidapril hydrochloride (IMD), enalapril maleate, (ENA) and lisinopril (LIS) in solid state with magnesium stearate noticed when Magnesium stearate and drugs undergo hydrolysis and cyclization to give various drug degradation products [17] .
PEG
In many literature authors revealed that polyoxyethylene linkages containing substances such as polysorbate surfactants, poloxamers, and PEGs undergo auto-oxidation, resulting in the formation of hydroperoxides and peroxidefree radicals. Steps in Auto-oxidation reaction of PEG  Catalyzed by metal-and/or light-induced decomposition of polyoxyethylene chains.  Chain eaction propogation by consumption of oxygen and formation of hydroperoxides  Reaction termination by the decomposition of hydroperoxides and/or collision among free radicals.
Peroxides and other oxidizing species such as peroxide and hydroxyl radicals, in formulations containing low levels of residual peroxides, can thus lead to fast degradation of the active drug resulting in significantly compromised therapeutic activity [18] .
Cetrizine
Oxidative degradation of cetirizine occurs in polyethylene glycol. The reaction between the drug and the reactive peroxide intermediates such as peroxyl radicals formed through oxidation of PEG. Oxidation of cetirizine produce as cetirizine N-oxide as degradation product [19] .
Cetirizine and PEG undergo esterification due to free carboxylic group and formation of Cetirizine PEG Esters, and Di-Cetirizine PEG Esters [20].
Indomethacine
The esterification of Indomethacine with PEG leads to formation of esterified products such as PEG esters of indomethacin and di-indomethacin PEG esters. The reported two hydrolysis products [5-methoxy-2-methyl-1H-indol-3-yl] acetic acid and 4-chloro-benzoic acid as well as their PEG ester was also reported [20] . 
CITRIC ACID
In various formulations Citric acid used for pH stabilizer.Drug release rates and absorption were different at different pH level [14] . But some times it also react with drug components [21] .
Carvedilol and Codeine Phosphate
Esterification of Carvedilol (CAR) and Codeine Phosphate (COP) with citric acid (CA) alter drug biological action. Due to mechano-activation means co-milling of API and Citric acid causes faster reaction than in physical powder mixtures kept at accelerated storage conditions. It is characterized by thermal behavior in DSC, their SWAXS patterns and also by characteristic peaks in the Raman fingerprint region-Raman spectra [22] .
FUMARIC ACID
In some formulations Fumaric acid used to improve stability and moisture sensitivity via the dry granulation. It was observed that slow dissolution kinetics of fumaric acid prolongs an acidic microenvironment around the API granules and excipients leading to increased dissolution and increased absorption [23] . But due to fumaric acid, some drug excipient incompatibility found in formulations. 
FORMALDEHYDE
Formaldehyde and other aldehydes are known impurities in several excipients such as Starch, degradation product of lactose, Povidon and cross Povidon, packaging components. Formaldehyde reacts with amine functional group of drugs to form N-formyl adducts (hemiaminals) that can further react to form dimer [24] . 
Amlodipine
STARCH
Chemically, starches are polysaccharides, contains monosaccharides or sugar (glucose) molecules linked together with α-d-(1-4) and/or α-d-(1-6) linkages. Starch has been used as excipient in many novel drug delivery systems which acts as disintegrants, fillers or binders. Due to its partial cold water solubility, performs dual functions of both a disintegrant and a binder and in capsule filling processes, Starch and Star Cap Co-Processed Starch Excipients used as binders. As a result of its partial cold water solubility, starch functions exceptionally well in tablet manufacture by wet granulation applications and performs dual functions of both a disintegrant and a binder. In capsule filling processes, Starch function as effective binders [26] .
Seproxetine
Seproxetine maleate hemihydrate salt, a selective serotonin re-uptake inhibitor, showed incompatibilitybetween primary amine containing active metabolite of fluoxetinen with lactose and starch in a gelatin capsule dosage form. It undergoes Micheal addition to form 1-4 addition product in the presence of pregelatinized starch while a Maillard reaction product was formed [6].
TITANIUM DIOXIDE
Titanium dioxide specimens like Wackherr TiO 2 , prepared TiO 2 and Aeroxide P25 toward the photocatalytic synthesis widely used in pharmaceuticales. TiO 2 Wackherr has low cost than other therefore more useful when high photocatalyst loading is required at high substrate concentration. But periodically it causes incompatibilitywith drugs [27] .
Metoprolol
The comparision between photocatalytic activity of TiO 2 Wackherr and TiO 2 Degussa P25 under UV irradiation. Under UV, the process involving TiO 2 Wackherr significantly showed faster photocatalytic activity than direct photolysis. The Transformation with Degussa P25 it is due to the higher radiation scattering by Degussa P25 compared to TiO 2 Wackherr ensures that the former photocatalyst is less efficient in using radiation. Fourteen intermediates were identified by LC-MS/MS (ESI+). 
OLEIC ACID
Oleic acid (OA), commonly used as vehicle in many pharmaceuticals. OA added in the formulations to increase drug solubility. But during purification by aid of distillation, dehydrated oleic acid formation leads to incompatibility between drugs and excipient.
WR 30090 (Mefloquine and Halofantrine Analog)
Incompatibility between novel antimalarial WR 30090 an analog of mefloquine and hal of antrine were observed when it formulated in a high purity sample of oleic acid as the vehicle. WR 30090 showed considerable chemical instability to form Oleic acid ester of WR 30090.It was due to oleic acid anhydrate which was prepared by fraction distillation of oleic acid.
The lipid lowering agent, 3-(2,4 diflurophenyl)-1heptyl-1-(neopentylbenzyl)urea (3), also formulated with oleic acid. On storage 3 rapidly degraded to a complex mixture with two of the degradation products identified shown in Fig. 26 [29] . 
PVP
Nitrates, nitrites are common nitrosating impurities that can be found in most excipients at parts per million (ppm) levels. Sodium starch glycolate, croscarmellose sodium, pre-gelatinized starch, PVP, cPVP. Many literature revealed that it also contain peroxides. The drugs containing functional groups that can potentially form NOCs with PVP, cPVP include dialkyl, alkylaryl, diaryl, cyclic secondary amines, N-alkylureas, Nalkylcarbamates and N-alkylamides to synthesize nitrosamines or nitrosamides products. To a much lesser extent, tertiary amines, cyanamides, guanidines, amidines, hydroxylamines, hydrazines, hydrazones and hydrazides may also form NOCs [24] .
Raloxifen
N-oxidative degradation product of raloxifene and povidon and crospovidone were observed [30].
CONCLUSION
Structure characteristics like molecular functional groups, their reactivity and chemical nature of the molecules and excipients shall be considered in predicting the drug excipient interactions and compatability. Drug, excipients degradated product, susceptible degradation factors such as micro environmental factors, metal ion, storage conditions, impurities, peroxide content and manufacturing details should be checked and ensured before finalizing the excipients. This article gives an idea about how the reactive functional groups in drugs will react with excipients in drug formulation. Best excipient, storage conditions and its prevention of drug excipient interaction establishing the good formulation. Advanced analytical development should ensure any unknown peaks formed during the drug excipient compatibility studies helps to ensure drug compatibility. Thorough monitoring and prevention of unknown impurities and its origin during drug development process reduces the delay in the product filings and USFDA approvals.
